Licensable university IP

Genome editing of graft-derived T-cells for post-transplant immunotherapy

Genome editing of graft-derived T-cells for post-transplant immunotherapy is marketed for licensing by Stanford University (OTL). It is documented in US patent US 11,903,969. The current assignee of record is Leland Stanford Junior University. Google Patents reports its legal status as “Active” (an automated indicator, not a legal determination). Its expected expiration is 2042-03-19.

Patent picture

Field	Value	Reliability	Source
US patent	US 11,903,969	95%High	Google Patents
Patent title	Genome editing of graft-derived T-cells for post-transplant immunotherapy	90%High	Google Patents
Current assignee	Leland Stanford Junior University	80%Good	Google Patents
Original assignee	Leland Stanford Junior University	85%Good	Google Patents
Legal status	Active	70%Moderate	Google Patents
Filing date	2020-11-13	90%High	Google Patents
Priority date	2019-11-13	90%High	Google Patents
Publication date	2024-02-20	90%High	Google Patents
Expected expiration	2042-03-19	75%Moderate	Google Patents

Reliability of each field, at a glance:

High 90% and up
Good 80 to 89%
Moderate 70 to 79%

Hover a bar for the exact figure; the Source column links the citation.

Legal status is Google Patents' automated indicator, not a legal determination.

Joined to US 11,903,969 by its printed patent number (a deterministic match), then enriched from public Google Patents data. Fields are shown only where resolved against a public source; unresolved fields are omitted, never guessed.

Original listing

This technology is marketed for licensing by Stanford University (OTL). View the original listing.